Winter 2016 issue of Spot ON | Varian

Winter 2016 issue of Spot ON

 
News from Varian's Particle Therapy Group         January 2016

Welcome to the Winter 2016 issue of Spot ON, a quarterly e-newsletter from Varian Medical Systems' Particle Therapy group. This e-newsletter is intended to offer subscribers the latest news about Varian's proton therapy offerings, including information about new technological developments and system deployments around the world. We welcome your comments and input, and hope that you find this quarterly e-newsletter of interest.

INDEX

Scripps Physician Co-Authors Journal Article on the Management of Lung Cancer with Proton Beam Therapy

Multi-Institutional Retrospective Review Suggests Proton Therapy Potentially of Benefit to Patients Receiving Treatment for Esophageal Cancer

Feature Spot: Varian Introduces Upgradeable Single-Room Proton Therapy System

Varian Received CE Mark and Saudi Authorization for Latest ProBeam® Proton Therapy System, and FDA 510(k) Clearance for Proton Treatment Planning Enhancements

Varian Launches Proton Therapy Advisory Board

Scripps Physician Co-Authors Journal Article on the Management of Lung Cancer with Proton Beam Therapy

 

Multi-Institutional Retrospective Review Suggests Proton Therapy Potentially of Benefit to Patients Receiving Treatment for Esophageal Cancer

Among the conclusions: PBT "appears to significantly reduce acute and subacute treatment-related toxicities."

FEATURE SPOT

Varian Introduces Upgradeable Single-Room Proton Therapy Solution

The entry-level ProBeam® Compact Single-Room Solution offers a cost-effective way to acquire Varian's best-in-class proton therapy treatment technology, imaging, motion management and software. Read more

Varian Received CE Mark and Saudi Authorization for Latest ProBeam Proton Therapy System, and FDA 510(k) Clearance for Proton Treatment Planning Enhancements

 

The ProBeam system with Dynamic Peak™ scanning gives clinicians the ability to deliver dose very precisely. It is uniquely capable of high-speed intensity modulated proton therapy (IMPT), enabling modulation of the dose on a spot-by-spot, layer by layer basis throughout the treatment area. Scanning beam technology also eliminates the time-consuming need to manually insert separate shaping accessories for each beam angle in order to match the beam to the shape of the tumor.

The Acuros PT dose calculation algorithm is designed to improve the accuracy of proton dose calculations, especially in regions of the body where the tissues vary in density such as the lung, where air, bone, and soft tissue are in close proximity. The algorithm also considers the density of treatment accessories/beam shaping devices, and enables planning for treatment at a wide range of energies. Proton planning in Eclipse using the Acuros PT algorithm requires significantly less time than was previously required using other methods.

Varian Launches Proton Therapy Advisory Board

In keeping with its long-standing tradition of partnering with customers to address clinical challenges in radiation therapy, Varian has established an advisory board of radiation oncologists and physicists to help guide its Particle Therapy business. The fifteen advisory board members from prestigious institutions across the globe met for the first time in November to talk about Varian's strategy. "It's exciting that Varian is bringing together thought leaders to discuss how to further advance the field and provide greater patient access to proton therapy," observed Board member Steven Frank, M.D., Director, Division of Oncology and Cancer Programs at MD Anderson Cancer Center. Find out more about Varian's proton therapy offerings.